-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Upgrades Chemed to Buy, Raises Price Target to $550

Benzinga·09/02/2025 10:06:27
Listen to the news
Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $490 to $550.